Pharmacology of ACEA-1416: A potent systemically active NMDA receptor glycine site antagonist

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 107-114

  Ilyin, Victor I ^a,d   Whittemore, Edward R ^a   Tran, Minhtam ^a   Shen, Ke Zhong ^a,e   Cai, Sui Xiong ^a   Kher, Sunil M ^b   Keana, John F W ^b   Weber, Eckard ^a   Woodward, Richard M ^a,c  

^a Department of Pharmacokinetics and Drug Metabolism   (United States)

^b UNIVERSITY OF OREGON   (United States)

^c Acea Pharmaceuticals Inc   (United States)

^d INSTITUTE OF CELL BIOPHYSICS   (Russian Federation)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

AMPA receptor antagonist; Anticonvulsant; Neuroprotection; NMDA receptor glycine site antagonist

Indexed keywords

ACEA 1416; AMINO ACID RECEPTOR BLOCKING AGENT; AMPA RECEPTOR; ANTICONVULSIVE AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BIOAVAILABILITY; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; DRUG EFFECT; DRUG RECEPTOR BINDING; EMBRYO; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; XENOPUS LAEVIS;

EID: 0030605957     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00370-6     Document Type: Article

References (39)

1. Balster, R.L., R.S. Mansbach. K.L. Shelton, K.L. Nicholson, D.M. Grech, J. Wiley, H. Li and E. Weber, 1995, Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists, Behav. Pharmacol. 6, 577.
2. Bristow, L.J., P.H. Huston, L. Thorn and M.D. Tricklebank, 1993, The glycme/NMDA receptor antagonist. R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br. J. Pharmacol. 108, 1156.
3. Buchan, A.M., H. Lesiuk, K.A. Barnes, H. Li, Z.-G. Huang, K.E. Smith and D. Xue, 1993. AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?. Stroke 24 (Suppl. I), 1-148.
4. Dickenson, A.H. and E. Aydar, 1991, Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat, Neurosci. Lett. 121, 266.
5. Gundersen. C.B., R. Miledi and I. Parker, 1984. Glutamate and kainate receptors induced in Xenopus oocytes, Proc. R. Soc. London B 221, 106.
6. Hargreaves, R.J., M. Rigby, D. Smith and R.G. Hill, 1993, Lack of effect of L-687-414 ((+ )-cis-4-methyl-HA-966). an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology, Br. J. Pharmacol. 110, 36.
7. A receptor, Mol. Pharmacol. 49, 897.
8. Honore, T.G., S.N. Davies, J. Drejer, E.J. Fletcher, P. Jacobsen, D. Lodge and F.E. Nielsen, 1988, Quinoxalinediones; potent competitive non-NMDA glutamate receptor antagonists. Science (Washington D.C.) 241, 701.
9. Keana, J.F.W., S.M. Kher, S.X. Cai, C.M. Dinsmore, A.G. Glenn, J. Guastella, J.-C. Huang, V. Ilyin, Y. Lu, P.L. Mouser, R.M. Woodward and E. Weber, 1995. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of the glycine site on the NMDA receptor and of non-NMDA glutamate receptors. J. Med. Chem. 38, 4367.
10. Kemp, J.A. and P.D. Leeson, 1993. The glycine site of the NMDA receptor - five years on, Trends Pharmacol. Sci. 14, 20.
11. Kher, S.M., S.X. Cai, E. Weber and J.F.W. Keana, 1995, Regiospecific oxidative nitration of 3,4-dihydro-6,7-disubstituted quinoxaline-2(1H)-ones gives 1,4-dihydro-5-nitro-6,7-disubstituted qunioxaline-2,3-diones, potent antagonists at the NMDA/glycine site, J. Org. Chem. 60, 5838.
12. Koek, W. and F.C. Colpaert, 1990. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects, J. Pharmacol. Exp. Ther. 252, 349.
13. Leeson, P.D. and L.L. Iversen, 1994, The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J. Med. Chem. 37, 4053.
14. Leff, P. and I.G. Dougall, 1993. Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci. 14, 110.
15. Leonard, J.P. and S.R. Kelso, 1990. Apparent desensitization of NMDA responses in Xenopus oocytes involves calcium-dependent chloride current. Neuron 2, 53.
16. Lingenhohl, K., T. Ferrat and R. Hiltscher, 1995. ACEA-1021: an antagonist at the strychnine-insensitive glycine receptor - electro-physiological characterization in vivo, Soc. Neurosci. Abstr. 7, 1106.
17. Lutfy, K., J.F.W. Keana and E. Weber, 1995, ACEA-1011, a novel NMDA receptor glycine site antagonist produces antinociception but not tolerance in the formalin test in mice. NIDA Res. Monograph 147, 220.
18. Manzoni, O., L. Fagni, J.-P. Pin, F. Rassendren, F. Poulat, F. Sladeczek and J. Bockaert, 1990. (trans)-1-Amino-cyclopentyl-1,3-dicarboxylate stimulates quisqualate phosphoinositide-coupled receptors but not ionotropic glutamate receptors in striatal neurons and Xenopus oocytes, Mol. Pharmacol. 38, 1.
19. McCulloch. J., 1992, Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br. J. Clin. Pharamcol. 34, 106.
20. Millan, M.J. and L. Seguin, 1993, (+)-HA-966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice. Eur. J. Pharmacol. 238, 445.
21. Olney, J.W., J. Labruyere and M.T. Price, 1989. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (Washington D.C.) 244, 1360.
22. Oron, Y., N. Dascal, E. Nadler and M. Lupu, 1985, Inositol 1.4.5-trisphosphate mimics muscarinic response in Xenopus oocytes. Nature (London) 313, 141.
23. Parke, C.K., D.G. Nehls, D.I. Graham, G.M. Teasdale and J. McCulloch, 1988, The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat, Ann. Neurol. 24, 543.
24. Patneau, D.K. and M.L. Mayer, 1991. Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse neurons. Neuron 6, 785.
25. Randle, J.C.R., T. Guet, C. Bobichon, C. Moreau, P. Curutchet, B. Lambolez, L. Prado De Carvalho, A. Cordi and J.M. Lepagnol, 1992 Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate-and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Mol. Pharmacol. 41, 345.
26. Rogawski, M.A., 1992, The NMDA receptor, NMDA antagonists and epilepsy therapy, Drugs 44, 279.
27. Sheardown, M.J., E.O. Neilsen, A.J. Hansen, P. Jacobsen and T. Honore, 1990, 2,3-Dihydro-6-nitro-7-sulfamoylbenzo(F)quinoxaline: a neuroprotectant for cerebral ischemia, Science (Washington D.C.) 247, 571.
28. Swartz, K.J., W.J. Koroshetz, A.H. Rees and J.E. Huettner, 1992, Competitive antagonism of glutamate receptor channel by substituted benzazepines in cultured cortical neurons. Mol. Pharmacol. 41, 1130.
29. Swinyard, E.A., 1972, Assay of antiepileptic drug activity in experimental animals: standard tests, in: Anticonvulsant Drugs. International Encyclopedia of Pharmacology and Therapeutics, ed. J. Mercier (Pergamon, Oxford) p. 47.
30. Tricklebank, M.D., L. Singh, R.J. Oles, C. Preston and S.D. Iversen, 1989. The behavioral effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167, 127.
31. Tricklebank, M.D., L.J. Bristow, P.H. Huston, P.D. Leeson, M. Rowley, K. Saywell, L. Singh, F.D. Tattersall, L. Thorn and B.J. Williams, 1994, The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex, Br. J. Pharmacol. 113, 729.
32. Tsuchida, E. and R. Bullock, 1995, The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA 1021 on ischemic brain damage caused by acute subdural hematoma in the rat, J. Neurotrauma 12, 279.
33. Vaccarino, A.L., P. Marek, B. Kest, E. Weber, J.F.W. Keana and J.C. Liebeskind. 1993, NMDA receptor antagonists, MK-801 and ACEA-1011. prevent the development of tonic pain following subcutaneous formalin. Brain Res. 615, 331.
34. Warner, D.S., H. Martin, P. Ludwig, A. Mc Allister, J.F.W. Keana and E. Weber, 1995, In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists, J. Cereb. Blood Flow Metab. 15, 188.
35. Whittemore, E.R., D.T. Loo, J.A. Watt and C.W. Cotman, 1995, A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture, Neuroscience 67, 921.
36. Williams, K., 1993, Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors, Mol. Pharmacol. 44, 851.
37. +RNA from mammalian brain and retina, Mol. Pharmacol. 41, 89.
38. Woodward, R.M., J.E. Huettner, J. Guastella, J.F.W. Keana and E. Weber, 1995a, In vitro pharmacology of ACEA-1021 and ACEA-1031 : systemically active quinoxalinediones with high affinity and selectivity for NMDA receptor glycine sites, Mol. Pharmacol. 47, 568.
39. Woodward, R.M., J.E. Huettner, M.T. Tran, J. Guastella, J.F.W. Keana and E. Weber, 1995b, Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydroquinoxaline-2,3-dione: a novel systemically active ionotropic glutamate receptor antagonist, J. Pharmacol. Exp. Ther. 275, 1209.